FDA Requires Chantix to Have Mental Health Warning

By: Associated Press Email
By: Associated Press Email

NEW YORK (AP) - The Food and Drug Administration will require Pfizer Inc.'s smoking cessation drug Chantix to carry the agency's strongest safety warning over a series of mental health side effects, including depression and suicidal thoughts.

The new requirement is based on reports of people experiencing
unusual changes in behavior, becoming depressed, or having suicidal
thoughts while taking the drug.

Pfizer Inc. had already updated the drug's labeling, following the beginning of an FDA investigation into the potential side effects in 2007.

The FDA is also requiring an additional study on the drugs to determine the extent of the side effects.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KOLO-TV 4850 Ampere Drive Reno, NV 89502
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 49611382 - kolotv.com/a?a=49611382
Gray Television, Inc.